164 related articles for article (PubMed ID: 31797615)
21. Integrative analysis of survival-associated gene sets in breast cancer.
Varn FS; Ung MH; Lou SK; Cheng C
BMC Med Genomics; 2015 Mar; 8():11. PubMed ID: 25881247
[TBL] [Abstract][Full Text] [Related]
22. Improved nonparametric survival prediction using CoxPH, Random Survival Forest & DeepHit Neural Network.
Asghar N; Khalil U; Ahmad B; Alshanbari HM; Hamraz M; Ahmad B; Khan DM
BMC Med Inform Decis Mak; 2024 May; 24(1):120. PubMed ID: 38715002
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Li G; Wang G; Guo Y; Li S; Zhang Y; Li J; Peng B
World J Surg Oncol; 2020 Sep; 18(1):249. PubMed ID: 32950055
[TBL] [Abstract][Full Text] [Related]
24. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
[TBL] [Abstract][Full Text] [Related]
25. A plea for taking all available clinical information into account when assessing the predictive value of omics data.
Volkmann A; De Bin R; Sauerbrei W; Boulesteix AL
BMC Med Res Methodol; 2019 Jul; 19(1):162. PubMed ID: 31340753
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction based on microarray analysis: a critical perspective on methods.
Zervakis M; Blazadonakis ME; Tsiliki G; Danilatou V; Tsiknakis M; Kafetzopoulos D
BMC Bioinformatics; 2009 Feb; 10():53. PubMed ID: 19200394
[TBL] [Abstract][Full Text] [Related]
27. Combining gene signatures improves prediction of breast cancer survival.
Zhao X; Rødland EA; Sørlie T; Naume B; Langerød A; Frigessi A; Kristensen VN; Børresen-Dale AL; Lingjærde OC
PLoS One; 2011 Mar; 6(3):e17845. PubMed ID: 21423775
[TBL] [Abstract][Full Text] [Related]
28. High-dimensional Cox models: the choice of penalty as part of the model building process.
Benner A; Zucknick M; Hielscher T; Ittrich C; Mansmann U
Biom J; 2010 Feb; 52(1):50-69. PubMed ID: 20166132
[TBL] [Abstract][Full Text] [Related]
29. Integration of multiple types of genetic markers for neuroblastoma may contribute to improved prediction of the overall survival.
Polewko-Klim A; Lesiński W; Mnich K; Piliszek R; Rudnicki WR
Biol Direct; 2018 Sep; 13(1):17. PubMed ID: 30236139
[TBL] [Abstract][Full Text] [Related]
30. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
Matsuo K; Purushotham S; Jiang B; Mandelbaum RS; Takiuchi T; Liu Y; Roman LD
Am J Obstet Gynecol; 2019 Apr; 220(4):381.e1-381.e14. PubMed ID: 30582927
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
32. Survival prediction models: an introduction to discrete-time modeling.
Suresh K; Severn C; Ghosh D
BMC Med Res Methodol; 2022 Jul; 22(1):207. PubMed ID: 35883032
[TBL] [Abstract][Full Text] [Related]
33. Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets.
Murtojärvi M; Halkola AS; Airola A; Laajala TD; Mirtti T; Aittokallio T; Pahikkala T
Int J Med Inform; 2020 Jan; 133():104014. PubMed ID: 31783311
[TBL] [Abstract][Full Text] [Related]
34. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Song YZ; Li X; Li W; Wang Z; Li K; Xie FL; Zhang F
World J Gastroenterol; 2018 Jul; 24(28):3145-3154. PubMed ID: 30065560
[TBL] [Abstract][Full Text] [Related]
35. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
36. Comparison of pathway and gene-level models for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Bioinformatics; 2020 Feb; 21(1):76. PubMed ID: 32111152
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
38. Feature selection and survival modeling in The Cancer Genome Atlas.
Kim H; Bredel M
Int J Nanomedicine; 2013; 8 Suppl 1(Suppl 1):57-62. PubMed ID: 24098079
[TBL] [Abstract][Full Text] [Related]
39. Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.
Zhao Q; Shi X; Xie Y; Huang J; Shia B; Ma S
Brief Bioinform; 2015 Mar; 16(2):291-303. PubMed ID: 24632304
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
